Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marianna.nalli@uniroma1.it
Marianna Nalli
Ricercatore
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
marianna.nalli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
EUROPEAN JOURNAL OF PHARMACOLOGY
2021
Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer
BIOLOGY DIRECT
2021
Discovery of a novel class of norovirus inhibitors with high barrier of resistance
PHARMACEUTICALS
2021
Emerging therapeutic agents for colorectal cancer
MOLECULES
2021
Discovery of new 1,1'-biphenyl-4-sulfonamides as selective subnanomolar human carbonic anhydrase II inhibitors
ACS MEDICINAL CHEMISTRY LETTERS
2020
Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2020
Discovery of Zika virus NS2B/NS3 inhibitors that prevent mice from fife-threatening infection and brain damage
ACS MEDICINAL CHEMISTRY LETTERS
2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2020
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
2020
Sulfonamide inhibitors of beta-Catenin signaling as anticancerAgents with different output on c-Myc
CHEMMEDCHEM
2020
Discovery of Kynurenines containing oligopeptides as potent opioid receptor agonists
BIOMOLECULES
2020
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents
ACS MEDICINAL CHEMISTRY LETTERS
2019
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2018
3-Aroyl-1,4-diarylpyrroles inhibit chronic myeloid leukemia cell growth through an interaction with tubulin
ACS MEDICINAL CHEMISTRY LETTERS
2017
Effects of curcumin and curcumin analogues on TRP channels
FITOTERAPIA
2017
Arylboronic acids as dual-action FAAH and TRPV1 ligands
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2016
TRPA1 channels as targets for resveratrol and related stilbenoids
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2016
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer
JOURNAL OF MEDICINAL CHEMISTRY
2015
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
BRITISH JOURNAL OF PHARMACOLOGY
2015
Progetti di Ricerca
Brain-penetrant microtubule-targeting agents.
New 3-Aroyl-1-arylpyrroles (ARAPs) as anticancer drugs thought an interaction at Colchicine site of Tubulin
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma